Inj pitocin use
Reading File
Finding Sources
Searching PubMed
oxytocin labor induction uterotonic
Reading File
Reading File
Reading File
Excellent - rich data from three authoritative sources. Let me now compile the full answer.
Injection Pitocin (Oxytocin) - Complete Clinical Guide
What is it?
Pitocin is the brand name for synthetic oxytocin, a nonapeptide identical to the endogenous posterior pituitary hormone. It is available as an injectable solution (10 U/mL) given by IV infusion or IM injection.
Mechanism of Action
Oxytocin acts on specific G-protein coupled receptors (OTRs) on uterine myometrial cells. Receptor binding triggers:
- Increased intracellular calcium - direct smooth muscle contraction
- Sensitization of the myometrium to estrogen (estrogen up-regulates OTRs near term)
- Stimulation of prostaglandin synthesis, which amplifies contractions
At high doses, oxytocin also activates vasopressin V2 receptors, causing antidiuretic (water-retaining) effects.
Indications
| Indication | Detail |
|---|---|
| Induction of labor | When risk of continued pregnancy > risk of induction (e.g., post-dates, IUGR, pre-eclampsia, PROM) - requires a ripened cervix |
| Augmentation of labor | When spontaneous labor is inadequately progressing (hypotonic contractions) |
| Prevention of PPH | Administered immediately after delivery of the placenta - standard of care |
| Treatment of uterine atony/PPH | First-line uterotonic for postpartum hemorrhage |
| Milk ejection | Oxytocin nasal spray used off-label; parenteral form not for this |
Important FDA note: Pitocin is NOT indicated for elective induction of labor (i.e., induction with no medical indication). The available data are considered inadequate to justify the benefit-to-risk ratio for elective use.
- Goodman & Gilman's Pharmacological Basis of Therapeutics
Dosing Protocols
Labor Induction/Augmentation (IV Infusion only)
| Protocol | Starting Dose | Increments | Notes |
|---|---|---|---|
| Low-dose | 0.5 - 2 mU/min | Increase every 30-40 min | Preferred; lower hyperstimulation risk |
| High-dose | 6 mU/min | Increase every 15-40 min | Faster effect; higher hyperstimulation risk |
| Typical range | Up to 8 mU/min (some protocols up to 20-40 mU/min) | Titrate to 3 contractions/10 min | Stop if fetal distress appears |
Half-life: 3-15 minutes (variously reported as 3-5 min clinically; 12-15 min to steady state). Steady-state uterine response achieved in ~30 minutes.
Postpartum Hemorrhage Prevention/Treatment
| Route | Dose | Preparation |
|---|---|---|
| IV infusion (preferred) | 20-50 U in 1 L NS/LR | Run at rate sufficient to maintain uterine tone |
| IM | 10 U | Single injection after delivery |
| IV bolus | AVOID - causes hypotension | Use controlled infusion instead |
- Creasy & Resnik's Maternal-Fetal Medicine and Morgan & Mikhail's Clinical Anesthesiology
Side Effects and Complications
Maternal
| Effect | Mechanism | Clinical Significance |
|---|---|---|
| Hypotension | Relaxation of vascular smooth muscle (vasodilation) | Especially with rapid IV bolus; may be severe |
| Reflex tachycardia | Baroreceptor response to hypotension | Usually transient |
| Water intoxication / Hyponatremia | V2 receptor activation - antidiuretic effect | Prolonged high-dose infusion; can cause seizures |
| Uterine hyperstimulation | Excessive contractions (>5 in 10 min) | Fetal distress, placental abruption |
| Uterine tetany | Sustained, non-relaxing contraction | Fetal asphyxia; requires immediate cessation |
| Nausea/Vomiting | Central effect | Less common |
Fetal
- Fetal distress (non-reassuring FHR) due to hyperstimulation and reduced uteroplacental perfusion
- Fetal bradycardia from tetanic contractions
Deep/general anesthesia can exaggerate oxytocin's hypotensive effect by blunting the reflex tachycardia compensation. Volatile agents should be reduced to 0.5 MAC in obstetric patients under GA.
- Morgan & Mikhail's Clinical Anesthesiology, 7e
Contraindications
- Elective induction (no medical indication)
- Cephalopelvic disproportion (CPD) - significant or absolute
- Unfavorable fetal position that cannot be corrected prior to delivery
- Obstetric emergencies requiring immediate surgical delivery
- Placenta previa or vasa previa
- Prior classical (vertical) uterine incision or other uterine surgery with risk of rupture
- Active herpes genitalis (if vaginal delivery contraindicated)
- Fetal distress where delivery is not imminent
Important Drug Interactions & Precautions
- Cyclopropane anesthesia - may cause maternal sinus bradycardia and abnormal AV rhythms; concurrent use with vasopressors can cause severe hypertension
- Vasopressors - enhanced pressor effect; monitor blood pressure closely
- Excessive antidiuretic effect at high doses - monitor fluid balance and serum sodium with prolonged infusions
Second-Line Uterotonics (If Pitocin Fails)
When oxytocin alone doesn't control uterine atony:
| Drug | Dose | Notes |
|---|---|---|
| Methylergonovine (Methergine) | 0.2 mg IM | Contraindicated in hypertension; never IV bolus |
| Carboprost tromethamine (Hemabate) | 0.25 mg IM q15-90 min (max 2 mg) | Contraindicated in asthma; causes bronchoconstriction |
| Misoprostol (PGE1) | 600-1000 mcg rectal/sublingual | No refrigeration needed; good resource-limited settings |
| Tranexamic acid | 1 g IV | Added for hemorrhage management (WOMAN trial) |
Key Clinical Pearls
- Always give by IV infusion, never rapid IV bolus for uterine atony - bolus causes acute vasodilation and dangerous hypotension.
- Continuous electronic fetal monitoring is mandatory during oxytocin infusion.
- Stop the infusion immediately if: fetal distress, uterine hyperstimulation (tachysystole), or tetanic contraction occurs.
- Oxytocin is on the "high-alert medication" list (ISMP) due to its potential for serious harm when used in error.
- Cervical ripening with prostaglandins (dinoprostone/misoprostol) should precede oxytocin induction when the cervix is unfavorable (Bishop score < 6).
- The antidiuretic effect at high doses is clinically significant - hyponatremia can cause maternal seizures; restrict hypotonic fluids.
Sources:
- Goodman & Gilman's Pharmacological Basis of Therapeutics, 14e - Clinical Use of Oxytocin
- Morgan & Mikhail's Clinical Anesthesiology, 7e - Obstetric Pharmacology
- Creasy & Resnik's Maternal-Fetal Medicine - Table of Oxytocic Medications
- Tietz Textbook of Laboratory Medicine, 7e - Oxytocin Physiology
This is a shared conversation. Sign in to Orris to start your own chat.